Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,133
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Location: Houston TX, Dallas TX, Memphis TN, St Louis MO,
Sponsor: Turning Point Therapeutics, Inc.
Sex: All
Age: 12+
Code: NCT03093116
Phase 1, Phase 2, Recruiting
Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia
for
Spinal Cord Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04533919
Recruiting
Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
for
Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 1 - 25
Code: NCT05645718
Phase 2, Recruiting
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Houston TX, Austin TX, San Antonio TX, Dallas TX,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05379985
Phase 1, Phase 2, Recruiting
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
for
Bladder Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Houston TX
Sponsor: Baylor College of Medicine
Sex: All
Age: 18+
Code: NCT03740256
Phase 1, Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
for
Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04047641
Phase 1, Phase 2, Recruiting
Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country